首页> 外国专利> HORMONE-INSENSITIVE PROSTATE CANCER THERAPY METHOD AND THERAPY EFFECT PREDICTION METHOD

HORMONE-INSENSITIVE PROSTATE CANCER THERAPY METHOD AND THERAPY EFFECT PREDICTION METHOD

机译:激素敏感型前列腺癌的治疗方法及治疗效果的预测方法

摘要

PPROBLEM TO BE SOLVED: To develop a novel method for therapy against hormone-insensitive prostate cancer. PSOLUTION: A therapy method which is heretofore not attainably excellent is provided by applying a combination of a sequential maximum androgen blockade (MAB) therapy and tegafur-uracil to a hormone-insensitive prostate cancer patient, especially a hormone-insensitive prostate cancer patient of an age of 70 or older. A more sufficient therapy effect is provided by selecting the prostate cancer patient according to the quantity of thymidylate synthetase (TS) gene expression as a marker. PCOPYRIGHT: (C)2011,JPO&INPIT
机译:

要解决的问题:开发一种针对激素不敏感的前列腺癌的新型治疗方法。

解决方案:通过对激素不敏感的前列腺癌患者,尤其是对激素不敏感的前列腺癌应用序贯最大雄激素阻断(MAB)治疗和替加氟尿嘧啶的联合治疗,提供了一种迄今无法达到的优异治疗方法70岁或以上的患者。通过根据胸苷酸合成酶(TS)基因表达的量选择前列腺癌患者作为标志物,可以提供更充分的治疗效果。

版权:(C)2011,日本特许厅&INPIT

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号